Status: Recruiting
Metabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery
Non-randomized, open-label, parallel-group clinical study evaluating the effects of endogenous bile acids on changes in plasma fibroblast growth factor-19 (FGF-19) and glucose metabolism by extended depletion of circulating bile acids using colesevelam as an experimental tool in subjects operated with gastric by-pass (RYGB).
Participants needed: 18
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Hvidovre University HospitalUpdated: Apr 13, 2025Locations: 1
Eligibility criteria
RYGB-operated ≥ 18 months prior to inclusion [+9]
Pregnancy or breastfeeding [+4]